(Q43294072)

English

Liver safety in patients with type 2 diabetes treated with pioglitazone: results from a 3-year, randomized, comparator-controlled study in the US.

scientific article published in January 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 November 2017

Liver safety in patients with type 2 diabetes treated with pioglitazone: results from a 3-year, randomized, comparator-controlled study in the US. (English)

1 reference

Europe PubMed Central

18 November 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

author name string

Keith G Tolman

1

1 reference

Europe PubMed Central

18 November 2017

James W Freston

2

1 reference

Europe PubMed Central

18 November 2017

Stuart Kupfer

3

1 reference

Europe PubMed Central

18 November 2017

Alfonso Perez

4

1 reference

Europe PubMed Central

18 November 2017

publication date

1 January 2009

1 reference

Europe PubMed Central

18 November 2017

1 reference

Europe PubMed Central

18 November 2017

32

1 reference

Europe PubMed Central

18 November 2017

9

1 reference

Europe PubMed Central

18 November 2017

787-800

1 reference

Europe PubMed Central

18 November 2017

https://scigraph.springernature.com/pub.10.2165/11316510-000000000-00000

0 references

Narrative review: hepatobiliary disease in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.2165%2F11316510-000000000-00000

21 January 2018

Glyburide-induced hepatitis

1 reference

https://api.crossref.org/works/10.2165%2F11316510-000000000-00000

21 January 2018

Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.2165%2F11316510-000000000-00000

21 January 2018

Evaluation of liver function in type 2 diabetic patients during clinical trials: evidence that rosiglitazone does not cause hepatic dysfunction

1 reference

https://pubmed.ncbi.nlm.nih.gov/19670918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/19670918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The liver and lovastatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/19670918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acetylation rates and monthly liver function tests during one year of isoniazid preventive therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19670918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monitoring the safety of pioglitazone : results of a prescription-event monitoring study of 12,772 patients in England

1 reference

https://pubmed.ncbi.nlm.nih.gov/19670918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adverse drug event monitoring at the Food and Drug Administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/19670918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/19670918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonalcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19670918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/19670918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19670918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor necrosis factor and its potential role in insulin resistance and nonalcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19670918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patients with elevated baseline liver enzymes do not have higher frequency of hepatotoxicity from lovastatin than those with normal baseline liver enzymes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19670918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glyburide-induced cholestatic hepatitis and liver failure. Case-report and review of the literature

1 reference

https://pubmed.ncbi.nlm.nih.gov/19670918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatotoxicity of the thiazolidinediones

1 reference

https://pubmed.ncbi.nlm.nih.gov/19670918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function

1 reference

https://pubmed.ncbi.nlm.nih.gov/19670918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hy's law: predicting serious hepatotoxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/19670918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Granulomatous hepatitis associated with glyburide

1 reference

https://pubmed.ncbi.nlm.nih.gov/19670918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Statins and hepatotoxicity: focus on patients with fatty liver

1 reference

https://pubmed.ncbi.nlm.nih.gov/19670918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dispelling myths and removing barriers about insulin in type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/19670918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/19670918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatotoxicity of thiazolidinediones

1 reference

https://pubmed.ncbi.nlm.nih.gov/19670918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem

1 reference

https://pubmed.ncbi.nlm.nih.gov/19670918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence of statin hepatotoxicity in patients with hepatitis C.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19670918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A cohort study of the incidence of serious acute liver injury in diabetic patients treated with hypoglycemic agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/19670918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Implications of the United Kingdom Prospective Diabetes Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19670918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preclinical evaluation of lovastatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/19670918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NIDDM patients' fears and hopes about insulin therapy. The basis of patient reluctance

1 reference

https://pubmed.ncbi.nlm.nih.gov/19670918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interactions between simvastatin and troglitazone or pioglitazone in healthy subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/19670918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rosuvastatin as a novel treatment of non-alcoholic fatty liver disease in hyperlipidemic patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19670918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of pioglitazone with other antidiabetic drugs for associated incidence of liver failure: no evidence of increased risk of liver failure with pioglitazone

1 reference

https://pubmed.ncbi.nlm.nih.gov/19670918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pravastatin in patients with nonalcoholic steatohepatitis: results of a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19670918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19670918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and tolerability of pioglitazone, metformin, and gliclazide in the treatment of type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/19670918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of rosiglitazone on serum liver biochemistries in diabetic patients with normal and elevated baseline liver enzymes

1 reference

https://pubmed.ncbi.nlm.nih.gov/19670918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/19670918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19670918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pioglitazone: a review of its use in type 2 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/19670918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries

1 reference

https://pubmed.ncbi.nlm.nih.gov/19670918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19670918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/11316510-000000000-00000

1 reference

Europe PubMed Central

18 November 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

18 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43294072&oldid=1607705869"